Evidence map›Paper›PMID 34949196›Full record

ArticleJournal of nanobiotechnology2021

Poly (N-vinylpyrrolidone) modification mitigates plasma protein corona formation on phosphomolybdate-based nanoparticles.

Youyi Yu, Behafarid Ghalandari, Guangxia Shen, Liping Wang, Xiao Liu, Aiting Wang, Sijie Li, Haiyang Xie, Xianting Ding

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Youyi YuState Key Laboratory of Oncogenes and Related Genes, Institute for Personalized Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China.
Behafarid GhalandariState Key Laboratory of Oncogenes and Related Genes, Institute for Personalized Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China.
Guangxia ShenState Key Laboratory of Oncogenes and Related Genes, Institute for Personalized Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China.
Liping WangState Key Laboratory of Oncogenes and Related Genes, Institute for Personalized Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China.
Xiao LiuState Key Laboratory of Oncogenes and Related Genes, Institute for Personalized Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China.
Aiting WangState Key Laboratory of Oncogenes and Related Genes, Institute for Personalized Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China.
Sijie LiState Key Laboratory of Oncogenes and Related Genes, Institute for Personalized Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China.
Haiyang XieState Key Laboratory of Oncogenes and Related Genes, Institute for Personalized Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China. hyxie@sjtu.edu.cn.
Xianting DingState Key Laboratory of Oncogenes and Related Genes, Institute for Personalized Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China. dingxianting@sjtu.edu.cn.

Funding

Innovative Research Group Project of the National Natural Science Foundation of China 22077079Innovative Research Group Project of the National Natural Science Foundation of China 81871448Shanghai Municipal Science and Technology Project 18430760500Shanghai Municipal Science and Technology Project 2017SHZDZX01
6 · The paper itself

Abstract

Phosphomolybdate-based nanoparticles (PMo

Indexed as

AdsorptionApolipoproteinsBlood ProteinsChromatography, High Pressure LiquidHumansMolecular Docking SimulationMolybdenumNanoparticlesPhosphoric AcidsPovidoneProtein CoronaSurface-Active AgentsSurface PropertiesTandem Mass SpectrometryApolipoproteinsBlood ProteinsMolybdenumphosphomolybdic acidPhosphoric AcidsPovidoneProtein CoronaSurface-Active AgentsMass spectrometryPhosphomolybdatePlasma protein coronaZwitterionic polymer poly (N-vinylpyrrolidone)

Identifiers

PMID34949196
PMCPMC8697440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.